KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Common Equity (2016 - 2025)

Resmed's Common Equity history spans 16 years, with the latest figure at $6.3 billion for Q4 2025.

  • For Q4 2025, Common Equity rose 20.33% year-over-year to $6.3 billion; the TTM value through Dec 2025 reached $6.3 billion, up 20.33%, while the annual FY2025 figure was $6.0 billion, 22.69% up from the prior year.
  • Common Equity reached $6.3 billion in Q4 2025 per RMD's latest filing, up from $6.1 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $6.3 billion in Q4 2025 to a low of $2.7 billion in Q1 2021.
  • Average Common Equity over 5 years is $4.3 billion, with a median of $4.2 billion recorded in 2023.
  • Peak YoY movement for Common Equity: grew 9.8% in 2021, then rose 23.81% in 2023.
  • A 5-year view of Common Equity shows it stood at $3.1 billion in 2021, then increased by 18.83% to $3.7 billion in 2022, then increased by 19.9% to $4.5 billion in 2023, then increased by 17.21% to $5.3 billion in 2024, then rose by 20.33% to $6.3 billion in 2025.
  • Per Business Quant, the three most recent readings for RMD's Common Equity are $6.3 billion (Q4 2025), $6.1 billion (Q3 2025), and $6.0 billion (Q2 2025).